Dutch Physician's Perspectives on Diagnosis and Treatment of Waldenstrom's Macroglobulinemia Before and After the Implementation of a National Guideline.

ABSTRACT: Waldenström's macroglobulinemia (WM), a rare low-grade B-cell non-Hodgkin lymphoma (NHL), has a distinct clinical presentation and different treatment-related side effects compared with other NHL. Currently, a wide variety of therapeutic agents are available for the treatment of WM but there is no consensus on optimal treatment in first line and/or at relapse. The aim of this survey was to evaluate the current knowledge and perspectives of hematologists on diagnosis and treatment of WM. Also, we compare these results to a similar survey done before the publication of the first Dutch national guideline, in order to evaluate the impact of the implementation of a national guideline. A link to an online survey was sent out to all registered hematologists and hemato-oncologists in the Netherlan

SUBMITTER: Amaador K 

PROVIDER: S-EPMC9259157 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature